AI English summary of an SEC filing — figures as filed
Altria MOThe company said adjusted diluted EPS for Q2 2024 was unchanged at $1.31, and first-half adjusted diluted EPS declined 1.6% to $2.46. It narrowed its full-year adjusted diluted EPS outlook to $5.07 to $5.15, which it said represents 2.5% to 4.0% growth from a base of $4.95 in 2023.
Key points
AI summaryThe company said adjusted diluted EPS for Q2 2024 was unchanged at $1.31, and first-half adjusted diluted EPS declined 1.6% to $2.46. It narrowed its full-year adjusted diluted EPS outlook to $5.07 to $5.15, which it said represents 2.5% to 4.0% growth from a base of $4.95 in 2023.
Altria said Q2 net revenues fell 4.6% to $6.2 billion, and reported diluted EPS rose 85.7% to $2.21. The company cited the pre-tax gain of $2.7 billion on the sale of the IQOS Tobacco Heating System commercialization rights as among the factors behind the increase in reported EPS.
The company said it recorded a non-cash, pre-tax impairment charge of $354 million on the Skoal trademark in Q2. It said it recorded a pre-tax charge of about $140 million tied to a change in the fair value of contingent payments related to the NJOY acquisition, and that it paid $250 million in July 2024 after the FDA granted marketing orders.
The company said it returned more than $5.8 billion to shareholders through share repurchases and dividends in the first half of 2024. It said it completed its $2.4 billion accelerated share repurchase program and that, as of June 30, $990 million remained under its currently authorized $3.4 billion program.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
Q2 and First-Half Adjusted Diluted EPS and Full-Year Outlook Range
The company said adjusted diluted EPS for Q2 2024 was unchanged at $1.31, and first-half adjusted diluted EPS declined 1.6% to $2.46. It narrowed its full-year adjusted diluted EPS outlook to $5.07 to $5.15, which it said represents 2.5% to 4.0% growth from a base of $4.95 in 2023.
Source · Based on the filing body and exhibits
Altria QQ2 Net Revenues, Reported EPS and IQOS Rights Sale Gain
Altria said Q2 net revenues fell 4.6% to $6.2 billion, and reported diluted EPS rose 85.7% to $2.21. The company cited the pre-tax gain of $2.7 billion on the sale of the IQOS Tobacco Heating System commercialization rights as among the factors behind the increase in reported EPS.
Source · Based on the filing body and exhibits
Skoal Trademark Impairment and NJOY Contingent Payment Items
The company said it recorded a non-cash, pre-tax impairment charge of $354 million on the Skoal trademark in Q2. It said it recorded a pre-tax charge of about $140 million tied to a change in the fair value of contingent payments related to the NJOY acquisition, and that it paid $250 million in July 2024 after the FDA granted marketing orders.
Source · Based on the filing body and exhibits
First-Half Shareholder Returns: Share Repurchases and Dividends
The company said it returned more than $5.8 billion to shareholders through share repurchases and dividends in the first half of 2024. It said it completed its $2.4 billion accelerated share repurchase program and that, as of June 30, $990 million remained under its currently authorized $3.4 billion program.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…